Preventing Prostate Cancer to Bone Metastasis
Monday, July 13, 2009 - 04:14
in Health & Medicine
(PhysOrg.com) -- In new research on prostate cancer to bone metastasis, Dr. Phillip Trackman of Boston University Henry M. Goldman School of Dental Medicine explains that the lysyl oxidase pro-peptide (LOX-PP) inhibits prostate cancer cell growth in vitro by inhibiting the activity of a key growth factor known as Fibroblast Growth Factor 2, or FGF-2.
Read the whole article on Physorg
More from Physorg
Related
- Study raises questions about prostate cancer therapies targeting IGF-1Thu, 1 May 2008, 0:28:24 EDT
- Proepithelin encourages cell growth and migration in prostate cancerThu, 26 Feb 2009, 11:00:42 EST
- Experimental agent reduces breast cancer metastasis to boneTue, 3 Nov 2009, 13:51:31 EST
- Researchers find cancer-inhibiting compound under the seaThu, 7 Aug 2008, 17:28:48 EDT
- Experimental insulin-like growth factor receptor inhibitor reduced pancreatic cancer growthTue, 14 Apr 2009, 13:49:41 EDT